1093.HK - CSPC Pharmaceutical Group Limited

HKSE - HKSE Delayed Price. Currency in HKD
15.360
-0.320 (-2.041%)
At close: 4:09PM HKT
Stock chart is not supported by your current browser
Previous Close15.680
Open15.600
Bid15.340 x 0
Ask15.360 x 0
Day's Range15.160 - 15.660
52 Week Range7.960 - 16.700
Volume20,360,452
Avg. Volume18,894,114
Market Cap95.893B
BetaN/A
PE Ratio (TTM)43.57
EPS (TTM)0.352
Earnings DateNov 21, 2017 - Nov 27, 2017
Forward Dividend & Yield0.12 (0.85%)
Ex-Dividend Date2017-05-31
1y Target Est16.64
  • Reuters4 days ago

    BRIEF-CSPC Pharmaceutical Group Appoints ‍Li Chunlei As Executive Director ​

    Dec 12 (Reuters) - Cspc Pharmaceutical Group Ltd: * ‍LI CHUNLEI WAS APPOINTED AS AN EXECUTIVE DIRECTOR OF COMPANY WITH EFFECT FROM 12 DECEMBER 2017.​ * LI CHUNLEI APPOINTED AS AN EXECUTIVE DIRECTOR Source ...

  • Reuters29 days ago

    BRIEF-CSPC Pharmaceutical Group announces change of shareholdings of substantial shareholder

    Nov 17 (Reuters) - Cspc Pharmaceutical Group Ltd * ‍Massive Giant Group transferred approximately 6.78% of total issued shares to Common Success International​ Source text for Eikon: Further company coverage:...

  • Reuterslast month

    BRIEF-CSPC Pharmaceutical Group posts 9-month profit attributable of HK$‍2.04​ bln

    Nov 15 (Reuters) - CSPC Pharmaceutical Group Ltd * 9-month profit attributable HK$‍2.04​ billion versus HK$1.57 billion * 9-month ‍ total revenue HK$11.21 billion versus HK$9.25 billion Source text for ...

  • Reuterslast month

    BRIEF-CSPC Pharmaceutical Group updates on approvals ​of granted clinical trial

    Nov 6 (Reuters) - CSPC Pharmaceutical Group Ltd: * Group's "HA121-28" and "alprostadil liposome injection" were granted clinical trial approvals ​ * Approvals granted by ‍china Food ...

  • PR Newswire4 months ago

    CSPC Pharmaceutical Announces 2017 Interim Results

    HONG KONG, Aug. 22, 2017 /PRNewswire/ -- CSPC Pharmaceutical Group Limited (1093.HK) ("CSPC Pharmaceutical" or the "Group"), a leading pharmaceutical company in China, is pleased to announce its interim results for the six months ended 30 June 2017 (the "Period"). During the Period, the Group recorded sales of approximately HK$7,202 million, representing an increase of 17.2% (or increase of 23.2% on a constant currency basis) over the same period of last year. Profit attributable to shareholders was approximately HK$1,313 million, up 27.1% (or up 33.6% on a constant currency basis) from the same period of last year.

  • PR Newswire9 months ago

    CSPC Pharmaceutical Announces 2016 Annual Results

    HONG KONG, March 20, 2017 /PRNewswire/ -- CSPC Pharmaceutical Group Limited (1093.HK) ("CSPC Pharmaceutical" or the "Group"), a leading pharmaceutical company in China, is pleased to announce its annual results for the year ended 31 December 2016 (the "Year"). During the Year, the Group recorded sales of approximately HK$12,369 million, representing an increase of 8.6% (or increase of 15.3% on a constant currency basis) over the previous year.